Sickle cell anaemia test kits priced less than Rs 50 in govt's bid to eradicate the disease

The ICMR-National Institute for Research in Reproductive Health, along with PGI Chandigarh and NIIH, conducted a comprehensive assessment and determined that point-of-care tests for sickle cell disease/trait among the high-risk population in India would be cost-effective if procured at Rs 100 per test or below.

from Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/2xOcPVq
via gqrds

Comments

Popular posts from this blog

SC transfers PIL seeking implementation of law on mental health care to NHRC

Women in India Report Higher Sleep Deprivation Than Men

Over 9.19 crore hospital admissions facilitated under Ayushman Bharat since 2018